BioSig Technologies (BSGM) director Gallagher received 34,091 shares
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Patrick Joseph Gallagher (director at BioSig Technologies Inc., BSGM) reported that they received 34,091 shares on Nov 18, 2022. After these transactions the filing shows 96,585 shares held directly.
- Reporting person
- Gallagher Patrick Joseph
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Nov 18, 2022 | Grant or award (A) | Common Stock1 | +34,091 | - | - | 96,585 direct |
Holdings before and after
- Common Stock: 62,494 to 96,585 direct
Other positions listed
- Common Stock: 2,400 indirect, By Amy E Gallagher Educational Trust
- Common Stock: 2,400 indirect, By Hans Gallagher Educational Trust
Footnotes from the filing
- 1. The shares of restricted stock were granted in lieu of remuneration for the Company's third quarter board meeting and shall be fully vested as of November 18, 2022, the date of the grant, based on a closing price of $0.44 per share.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Gallagher report in this BSGM Form 4?
Patrick Joseph Gallagher (director at BioSig Technologies Inc., BSGM) reported that they received 34,091 shares on Nov 18, 2022. After these transactions the filing shows 96,585 shares held directly.
How many BSGM shares does Gallagher hold after this filing?
The filing shows 96,585 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for BSGM
Earlier insider filings at BSGM
- Nov 23, 2022SEC Form 4: Foley Donald E was granted 45,455 shares, increasing direct ownership by 36% to 172,455 units
- Nov 23, 2022SEC Form 4: Barry James J was granted 34,091 shares
- Sep 12, 2022SEC Form 4: Sieckhaus John bought $4,550 worth of shares (5,000 units at $0.91), increasing direct ownership by 8% to 70,000 units
- Sep 12, 2022SEC Form 4: Londoner Kenneth L bought $43,372 worth of shares (52,466 units at $0.83), increasing direct ownership by 3% to 1,896,820 units
- Sep 8, 2022SEC Form 4: Londoner Kenneth L bought $6,207 worth of shares (7,250 units at $0.86), increasing direct ownership by 0.39% to 1,844,354 units
Keep researching BSGM
- BSGM insider tradesEvery buy and sale reported by BioSig Technologies Inc. officers, directors and large holders.
- What is Form 4?The SEC filing that reports a change in an insider's holdings, such as a purchase, sale, option exercise or grant, generally within two business days.
- Form 4 explainedForm 4 is the SEC filing that discloses when officers, directors and 10% owners buy or sell company stock, due within 2 business days. Learn every key field and code.
- Insider trading trackerThe latest insider buys and sales across every stock.
Quantisnow market dataNASDAQ
BSGM
BioSig Technologies Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
Get push alerts for BSGM
Full BSGM profile on Quantisnow Follow BSGM and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time